Delivery Order SPE2DB22D1002-SPE2DB25FLFK7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $2,832.92. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,734.47 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Gvoke HypoPen auto-injectors (1 mg/0.2 ml, 2-pack). The contract, which represents a non-competitive delivery order under an existing indefinite delivery vehicle, will be fulfilled from the vendor's Conshohocken, Pennsylvania location with a completion date of September 10, 2025. This award is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL dosage). This is a firm fixed-price delivery order with a ceiling value of $10,843.19 and an ultimate completion date of August 26, 2025. The award was competitively procured with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.46 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gvoke HypoPen 2-pack (1 mg/0.2 mL) auto-injectors. The contract, which is not set aside and was competitively awarded, specifies a firm fixed price structure with an ultimate completion date of June 2, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $16,139.59. This is a firm fixed price delivery order with an ultimate completion date of April 25, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,519.71 to AmerisourceBergen Drug Corp for Gvoke HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This firm fixed-price, competitively awarded contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order operates as a child contract under AmerisourceBergen's existing indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,028.47 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoPen 2-pack auto-injectors (0.5mg/0.1ml) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-competitive delivery order represents a firm fixed price transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The product is a glucagon emergency injection device used for treating severe...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of GVOKE HypopenPen auto-injectors (2-pack, 1 mg/0.2 ml formulation) with a ceiling value of $1,456.72. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, and performance will be executed from the company's location in Conshohocken, Pennsylvania. The order is set for ultimate completion by August 19, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,087.62 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract involves delivery to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside provisions were utilized for this award. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,383.14 to AmerisourceBergen Drug Corp for the supply of Gvoke HyperPen 2-Pack 1 mg/0.2 ml auto-injectors on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gvoke HyperPen is an emergency glucagon auto-injector used to treat...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLFK7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,501.51 to AmerisourceBergen Drug Corp for Gvoke HypoPen auto-injectors (1 mg/0.2 mL, 2-pack). This competitive award, issued on July 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating open competition among eligible contractors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, has demonstrated capability to meet Defense Logistics Agency requirements through consistent competitive awards across multiple therapeutic domains, including specialty medications, vaccines, and medical devices serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/28/25 |